Baroreflex Activation Therapy Lowers Blood Pressure in Patients With Resistant Hypertension

Cited by (601)

Items 301–400 of 601

1. Effect of baroreflex activation therapy on renal sodium excretion in patients with resistant hypertension
   Mark Lipphardt, Michael Johann Koziolek, Luca-Yves Lehnig, Ann-Kathrin C. Schäfer, Gerhard Anton Muller, Stephan Lüders, Manuel Wallbach · 2019 · Clinical Research in Cardiology
2. Procedures and devices to treat resistant hypertension in chronic kidney disease
   Rama Dilip Gajulapalli, Johnny Chahine, Florian Rader, Ashish Aneja · 2020 · Cleveland Clinic Journal of Medicine
3. Pathophysiologie der Hypertonie
   Jens Jordan · 2015 · Der Internist
4. Neurocardiac Axis Physiology and Clinical Applications
   Caroline F. Plott, Tarek Harb, Marios Arvanitis, Gary Gerstenblith, Roger Scott Blumenthal, Thorsten Martin Leucker · 2024 · IJC Heart & Vasculature
5. Invasive Treatment of Resistant Hypertension: Present and Future
   Christian Ott, Roland Erich Schmieder · 2014 · Current Hypertension Reports
6. First-in-man treatment of severe blood pressure variability with baroreflex activation therapy
   Christopher Nicholas Floyd, Muhammad Yasir Adeel, C. B. Wolff, Peter O.O. Julu, Mussadiq Shah, David Collier, Manish Saxena, Tim Brier, Fu Liang Ng, Vikas Kapil et al. · 2016 · International Journal of Cardiology
7. Top Ten Breakthroughs in Clinical Hypertension Research in 2022
   Qiaoxi Yang, Jun Cai · 2023 · Cardiovascular Innovations and Applications
8. Bioelectronic Therapeutics: A Revolutionary Medical Practice in Health Care
   Ishu Garg, Madhu Verma, Harish Kumar, Ravi Maurya, Tushar Negi, Prityush Jain · 2025 · Bioelectricity
9. The Baroreflex Mechanism Revisited
   A. Rabinovitch, M. Friedman, Doron Braunstein, Yaacov Biton, Ira Aviram · 2015 · Bulletin of Mathematical Biology
10. Central arteriovenous anastomosis in resistant hypertension?
    Markus Peter Schlaich, Dagmara Hering · 2015 · The Lancet
11. Rationale and evidence for the development of a durable device-based cardiac neuromodulation therapy for hypertension
    Bing Yang, Yue Wang, Fengxiang Zhang, Weizhu Ju, Hongwu Chen, Yuval Mika, Ricardo Aviv, Steven J. Evans, Daniel Burkhoff, Jie Wang et al. · 2018 · Journal of the American Society of Hypertension
12. Sympathetic overactivation predicts body weight loss in patients with heart failure
    Shuji Joho, Ryuichi Ushijima, Masaki Nakagaito, Koichiro Kinugawa · 2019 · Autonomic Neuroscience
13. Resistant Hypertension
    Hossein Ardeschir Ghofrani, Fred A. Weaver, Mitra K. Nadim · 2014 · Cardiology Clinics
14. Neuromodulation Device Therapy for Treatment of Hypertensive Heart Disease
    Thomas M. Todoran, Michael R. Zile · 2013 · Circulation Journal
15. Additional drug treatment in resistant hypertension
    Giuseppe Mancia · 2012 · Journal of Hypertension
16. Differences in the dynamic baroreflex characteristics of unmyelinated and myelinated central pathways are less evident in spontaneously hypertensive rats
    Michael James Turner, Toru Kawada, Shuji Shimizu, Masafumi Fukumitsu, Masaru Sugimachi · 2015 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
17. Hemodynamic responses to magnetic stimulation of carotid sinus in normotensive rabbits
    Jun Zhang, Qinqin Cao, Rongrong Li, Jingze Hu, Jiafei Dai, Hao Zhang, Huaiming Wang, Fang Yang, Ruidong Ye, Xinfeng Liu et al. · 2017 · Journal of Hypertension
18. Short and Long-Term Effect of Carotid Artery Stenting on Arterial Blood Pressure Measured through Ambulatory Blood Pressure Monitoring.
    Erkan Köklü, İsa Öner Yüksel, Şakir Arslan, Nermin Bayar, Fatma Köklü, Serkan Çay, Göksel Çağırcı, Selçuk Küçükseymen, Görkem Kuş · 2016 · Europe PMC (PubMed Central)
19. Device profile of the MobiusHD EVBA system for the treatment of resistant hypertension: overview of its mechanism of action, safety and efficacy
    Mark C. Bates, Gregg W. Stone, Chao-Yin Chen, Wilko Spiering · 2020 · Expert Review of Medical Devices
20. Autonomic Regulation of Inflammation in Conscious Animals
    Hélio César Salgado, Fernanda Brognara, Aline Barbosa Ribeiro, Renata Maria Lataro, Jaci Airton Castania, Luis Ulloa, Alexandre Kanashiro · 2023 · NeuroImmunoModulation
21. Hypotensive Effect of Electric Stimulation of Caudal Ventrolateral Medulla in Freely Moving Rats
    Žilvinas Chomanskis, Vytautas Jonkus, Tadas Danielius, Tomas Paulauskas, Monika Orvydaitė, Kazimieras Melaika, Osvaldas Rukšėnas, Vaiva Hendrixson, Saulius Ročka · 2023 · Medicina
22. Baroreflex activation therapy through electrical carotid sinus stimulation
    Jens Jordan, Jens Tank, Karsten Heusser, Hannes Reuter · 2024 · Autonomic Neuroscience
23. Update Arterielle Hypertonie 2015
    Peter R. Rickenbacher · 2015 · Praxis
24. Combination of a subcutaneous ICD in a patient with a baroreceptor activation device: Feasibility, safety, and precautions: A Case Report
    Liz Kuffer, Daniel Steven, Marcel Halbach, Jakob Lüker, Jan‐Hendrik van den Bruck, Arian Sultan · 2017 · Pacing and Clinical Electrophysiology
25. Interventional Treatment of Hypertension: A New Paradigm
    W. Schuyler Jones, Sreekanth Vemulapalli, Manesh R. Patel · 2013 · Current Cardiology Reports
26. Novel strategies for treatment of resistant hypertension
    Eric K. Judd, Suzanne Oparil · 2013 · Kidney International Supplements
27. Novel and Nonpharmacologic Approaches to Cardio-Protection in Hypertension
    Luca Donazzan, Felix Mahfoud, Dominik Linz, Sebastian Ewen, Christian Ukena, Michael Böhm · 2014 · Current Hypertension Reports
28. Carotid Baroreceptor Stimulation and Arteriovenous Shunts for Resistant Hypertension
    Nicholas Paivanas, John D. Bisognano, John P. Gassler · 2015 · Methodist DeBakey Cardiovascular Journal
29. Carotid Sinus/Nerve Stimulation for Treatment of Resistant Hypertension and Heart Failure
    Dali Yin, Konstantin V. Slavin · 2015 · Progress in neurological surgery
30. Efficacy of baroreflex activation therapy for the treatment of resistant hypertension
    Αlexandros Briasoulis, George L. Bakris · 2013 · EuroIntervention
31. Effect of Low Dose Atorvastatin Therapy on Baroreflex Sensitivity in Hypertensives
    Denisa Čelovská, Peter Kružliak, Luı́s Rodrigo, Jozef Gonsorcik, Peter Sabaka, Péter Gáspár, Delian P. Delev, Daniel Petrovič, Andrej Dukát, Ľudovít Gašpar · 2016 · High Blood Pressure & Cardiovascular Prevention
32. Present and Future of Interventional Treatment of Resistant Hypertension
    Ayhan Yoruk, Sinan S. Tankut, John P. Gassler, John D. Bisognano · 2017 · Current Hypertension Reports
33. Resistant hypertension in 2017
    Sartaj S. Hans, John P. Reilly · 2017 · Current Opinion in Cardiology
34. Bilateral Nephrectomy, the Forgotten Measure in the Treatment of Refractory Hypertension in Patients With End-Stage Renal Disease: A Case Report and Literature Review
    Mohammad Aldiabat, Khaled Alabdallah, Ahmad Kofahi, Shazia Aziz · 2020 · Cureus
35. The Road to Better Management in Resistant Hypertension—Diagnostic and Therapeutic Insights
    Elisabeta Bădilă, Cristina Japie, Emma Weiss, Ana-Maria Balahura, D. Bartos, Alexandru Scafa‐Udriște · 2021 · Pharmaceutics
36. Nonpharmacologic Treatment for Heart Failure
    Boniface Malangu, Gregg M. Lanier, William H. Frishman · 2020 · Cardiology in Review
37. In silico trial of baroreflex activation therapy for the treatment of obesity-induced hypertension
    John S. Clemmer, William Andrew Pruett, Robert L. Hester · 2021 · PLoS ONE
38. Management of resistant hypertension
    Mohanad A. Hasan, Merrill H. Stewart, Carl J. Lavie, Héctor O. Ventura · 2019 · Current Opinion in Cardiology
39. Predictive modeling of hemodynamics during viscerosensory neurostimulation via neural computation mechanism in the brainstem
    Jiho Lee, Junseung Mun, Minhye Choo, Sung‐Min Park · 2025 · npj Digital Medicine
40. CrossTalk opposing view: Which technique for controlling resistant hypertension? Carotid sinus stimulation
    Jens Jordan · 2014 · The Journal of Physiology
41. Renal Denervation in Heart Failure
    Michael Fong, David M. Shavelle, Fred A. Weaver, Mitra K. Nadim · 2015 · Current Hypertension Reports
42. Recent advances in the management of resistant hypertension
    Athanasios John Manolis, Manolis S. Kallistratos, Michael N. Doumas, Stamatina Pagoni, Leonidas E. Poulimenos · 2015 · F1000Prime Reports
43. The past decade in hypertension—facts, hopes, and hypes
    Thomas Unger · 2014 · Nature Reviews Cardiology
44. Barorezeptoraktivierungstherapie
    Manuel Wallbach, Michael Johann Koziolek, Rolf Wachter · 2018 · Der Internist
45. Baroreflex Activation Therapy for Resistant Hypertension and Heart Failure
    Anna Meta Dyrvig Kristensen, Manan Pareek, Michael Hecht Olsen, Deepak L. Bhatt · 2020 · US Cardiology Review
46. Baropacing as a new option for treatment of resistant hypertension
    Teba Alnima, Peter W. de Leeuw, Abraham A. Kroon · 2015 · European Journal of Pharmacology
47. The Year in Interventional Cardiology
    Simon R. Dixon, Robert D. Safian · 2012 · Journal of the American College of Cardiology
48. Management of Resistant Hypertension Based on Recommendations from Different Guidelines and the Systolic Blood Pressure Intervention Trial
    Sandeep Banga, Sudhir Mungee, Avani R Patel, Shantanu Singh, Tinoy J. Kizhakekuttu · 2019 · Cureus
49. A historical perspective on peripheral reflex cardiovascular control from animals to man
    Peter Sleight · 2014 · Experimental Physiology
50. Chronic activation of the baroreflex and the promise for hypertension therapy
    Thomas E. Lohmeier, Radu Iliescu · 2013 · Handbook of clinical neurology
51. The role of baroreflex activation therapy in sympathetic modulation for the treatment of resistant hypertension
    John P. Gassler, Petra S Lynch, John D. Bisognano · 2012 · Heart
52. Long-Term Follow-Up of Baroreflex Activation Therapy in Resistant Hypertension
    Sebastian Ewen, Michael Böhm, Felix Mahfoud · 2017 · Hypertension
53. Programmable Hypertension Control: Another Possible Indication for Implanted Pacemakers
    Duc H. Do, Kalyanam Shivkumar · 2017 · Journal of the American Heart Association
54. Electrical carotid sinus nerve stimulation attenuates experimental colitis induced by acetic acid in rats
    Jefferson Ícaro Soares, Thaís Marques da Silva, Jaci Airton Castania, Ulisses Ávila Reis, Luiz Felipe Moreira Roque, Adriana Barbosa Ribeiro, Hélio César Salgado, Aline Barbosa Ribeiro · 2023 · Life Sciences
55. Where and when Device Therapy May Be Useful in the Management of Drug-Resistant Hypertension
    Herbert D. Aronow, Jun Li, Sahil A. Parikh · 2014 · Current Cardiology Reports
56. Identifying Patients With Resistant Hypertension and Options for Clinical Management
    Tommy Tsang Cheung, Bernard M.Y. Cheung · 2012 · Future Cardiology
57. Interventionelle Strategien zur Behandlung der Hypertonie
    Rolf Wachter, Jan Menne · 2015 · Der Internist
58. Endovascular Baroreflex Amplification for Resistant Hypertension: What You Need to Know
    Jonathan Halim, Michelle Lycke, Jan Van der Heyden · 2020 · Future Cardiology
59. Electrical stimulation of the carotid sinus lowers arterial pressure and improves heart rate variability in l-NAME hypertensive conscious rats
    Gean Domingos-Souza, Fernanda Machado Santos‐Almeida, César A. Meschiari, Nathanne Santos Ferreira, Camila A. Pereira, Diana Martínez, Daniel Penteado Martins Dias, Luiz Eduardo Virgílio Silva, Jaci Airton Castania, Rita C. Tostes et al. · 2020 · Hypertension Research
60. Sympathetic hyperactivity, hypertension, and tachycardia induced by stimulation of the ponto-medullary junction in humans
    Tadashi Hamasaki, Toshitaka Yamakawa, Koichi Fujiwara, Haruki Harashima, Kota Nakamura, Yoshihiro Ikuta, Tatsuo Yamamoto, Yu Hasegawa, Tatsuya Takezaki, Akitake Mukasa · 2021 · Clinical Neurophysiology
61. Etiological Diagnosis and Personalized Therapy for Hypertension: A Hypothesis of the REASOH Classification
    Chong Bing Xu, Moran Li, Weilun Meng, Jun Young Han, Song Zhao, Jiamin Tang, Haotian Yang, Rusitanmujiang Maimaitiaili, Jiadela Teliewubai, Shikai Yu et al. · 2023 · Journal of Personalized Medicine
62. A new use of transcutaneous electrical nerve stimulation: Role of bioelectric technology in resistant hypertension (Review)
    Chenghua Wang, Pu Wang, Guoqing Qi · 2023 · Biomedical Reports
63. Intrathecal Clonidine via Lumbar Puncture Decreases Blood Pressure in Patients With Poorly Controlled Hypertension
    Chris B. Komanski, Richard L Rauck, James M. North, Kyung S. Hong, Robert DʼAngelo, Keith R. Hildebrand · 2015 · Neuromodulation Technology at the Neural Interface
64. From Bad Behaviour to Bad Biology: Pitfalls and Promises in the Management of Resistant Hypertension
    Ross D. Feldman, Eric P. Brass · 2013 · Canadian Journal of Cardiology
65. Overview of resistant hypertension: A glimpse of the cardiologist’s current standpoint
    Luís Paiva · 2012 · World Journal of Cardiology
66. Experience With an Innovative New Food and Drug Administration Pathway for First-in-Human Studies
    Chandan M. Devireddy, Mark C. Bates · 2014 · JACC: Cardiovascular Interventions
67. Renal Sympathetic Denervation for the Treatment of Systemic Hypertension
    Gordon M. Burke, D. Sica, W. Frishman · 2012 · Cardiology in Review
68. Stretching the carotid sinus to treat resistant hypertension
    Pierre‐Yves Courand, Pierre Lantelme · 2017 · The Lancet
69. CHRONOTHERAPY OF HYPERTENSION: CURRENT STATE OF THE SCIENTIFIC PROBLEM
    Vladimir M. Gorbunov, E. Yu. Fedorova, Платонова Елена Вячеславовна · 2017 · Rational Pharmacotherapy in Cardiology
70. Permanent Pacing Reduces Blood Pressure in Older Patients with Drug-resistant Hypertension: A New Pacing Paradigm?
    Bich Lien Nguyen, Michael Howard Burnam, Francesco Accardo, Angela Angione, Roberto Scacciavillani, CARLY PIERSON, Eli S. Gang · 2024 · Journal of Innovations in Cardiac Rhythm Management
71. Resistant Hypertension: A Brief Review of Pathophysiology
    Alexander Haber, Andrew Foy · 2024 · Journal of general internal medicine
72. Management of drug-resistant hypertension as a heterogeneous disorder
    Reza Tabrizchi · 2025 · Pharmacology & Therapeutics
73. Neuroprosthetic closed-loop strategy for sustained blood pressure reduction via simultaneous stimulation and recording from the spinal cord
    Mingeun Cho, Minhye Choo, Matthew Koh, Sunguk Hong, Junseung Mun, Ja Ho Koo, ChangHwa Oh, Sung‐Min Park · 2025 · Neurotherapeutics
74. Nichtmedikamentöse und medikamentöse Therapie bei arterieller Hypertonie
    Joachim D. Hoyer · 2012 · Herz
75. Update on advanced interventional neuromodulatory approaches to lower blood pressure
    Márcio Galindo Kiuchi, Revathy Carnagarin, Carl Johann Schultz, Sharad V. Shetty, Natalie C. Ward, Carlos Eduardo Rodrigues Santos, Markus Peter Schlaich · 2023 · Heart
76. Baroreflex activation therapy in advanced heart failure: A long‐term follow‐up
    Dong Wang, J. Mueller-Leisse, Henrike A K Hillmann, J. Eiringhaus, D. Berliner, Nizar Karfoul, J. Schmitto, A. Ruhparwar, J. Bauersachs, D. Duncker · 2024 · ESC Heart Failure
77. Adipositas-assoziierte Hypertonie
    Marcus May, Jens Jordan, Stefan Engeli · 2014 · Adipositas - Ursachen Folgeerkrankungen Therapie
78. [Resistant hypertension - progress in diagnosis and treatment].
    Elżbieta Szwench-Pietrasz, Elżbieta Florczak, Aleksander Prejbisz, Jacek Kądziela, Adam Witkowski, Andrzej Januszewicz · 2012 · PubMed
79. Hipertensión arterial resistente
    Pedro Armario, Anna Oliveras, Alejandro de la Sierra · 2013 · Revista Clínica Española
80. L’activation du baroréflexe par stimulation implantable du sinus carotidien dans le traitement de l’hypertension artérielle résistante
    Atul Pathak, M. Labrunée, Alexander Richard Vaccaro, Francesco Della Rosa, Thibaut Guiraud, Anne Pavy‐Le Traon, Michel Galinier, Jean‐Michel Sénard · 2013 · Archives des Maladies du Coeur et des Vaisseaux - Pratique
81. Baroreflex Activation Therapy in Heart Failure
    Guido M. Grassi, Eric G. Lovett · 2015 · Springer eBooks
82. Preferred Fourth-Line Pharmacotherapy for Resistant Hypertension: Are We There Yet?
    Hamish C. G. Prosser, Cynthia Gregory, Dagmara Hering, Graham S. Hillis, Greg J. Perry, Johan B. Rosman, Carl Johann Schultz, Mark Thomas, Gerald Francis Watts, Markus Peter Schlaich · 2017 · Current Hypertension Reports
83. Effect of baroreflex activation therapy on dipping pattern in patients with resistant hypertension
    Manuel Wallbach, Ellen Born, Ann-Kathrin C. Schäfer, Michael Johann Koziolek · 2022 · Journal of Clinical Hypertension
84. Emerging topics on basic research in hypertension: interorgan communication and the need for interresearcher collaboration
    Keisuke Shinohara · 2023 · Hypertension Research
85. Baroreflex Activation Therapy in Patients with Heart Failure with a Reduced Ejection Fraction
    Jean Marie Ruddy, Anne M. Kroman, Catalin F. Baicu, Michael R. Zile · 2023 · Cardiac Electrophysiology Clinics
86. Key challenges in exploring the rat as a preclinical neurostimulation model for aortic baroreflex modulation in hypertension
    Ibrahim Muhammad Salman · 2023 · Hypertension Research
87. Renal Denervation as a Novel Therapeutic Approach for Resistant Hypertension: Mechanisms, Efficacy and Future Directions
    Kristen Callender, Ikponmwosa Jude Ogieuhi, Victor Oluwatomiwa Ajekiigbe, BOLUWADURO ADEYEMI, Chinonyelum Emmanuel Agbo, Taiwo Ayokunle Falayi, Abiodun Oladejo, Joan Oluwadamilola Ajayi, Samuel Taiwo Ajewole, Faith Temiloluwa Adetayo et al. · 2024 · High Blood Pressure & Cardiovascular Prevention
88. Non-pharmacological methods in the treatment of resistant hypertension
    Kostadin N. Kichukov, H. Dimitrov, Lora K. Nikolova, Ivo Spasov Petrov, Mariya Petkova Tokmakova · 2012 · Folia Medica
89. InnovaSEC in Action: Cost-effectiveness of Barostim in the Treatment of Refractory Hypertension in Spain
    Marcelo Soto, Laura Sampietro-Colom, Joan Sagarra, Josép Brugada · 2016 · Revista Española de Cardiología (English Edition)
90. Influence of Clonidine on Antihypertensive Selective Afferent Vagal Nerve Stimulation in Rats
    Mortimer Gierthmuehlen, Debora Aguirre, Oscar F. Cota, Josef Zentner, Thomas Stieglitz, Dennis T. T. Plachta · 2016 · Neuromodulation Technology at the Neural Interface
91. Hypertension
    Ali Zahedmehr · 2017 · Elsevier eBooks
92. La terapia de activación de barorreceptores, un paso más en el tratamiento de la hipertensión arterial resistente y la insuficiencia cardiaca
    Fernando Jaén-Águila, Ricardo Roa-Chamorro, Javier Ramos‐Maqueda, C. López Espada, M.I. Rodríguez-Macías, Juan Diego Mediavilla-García · 2019 · Hipertensión y Riesgo Vascular
93. Resistant Hypertension
    Debbie Valsan, Umber Burhan, Geoffrey S. Teehan · 2016 · Advances in experimental medicine and biology
94. The Role of Nonpharmacologic Device Interventions in the Management of Drug-Resistant Hypertension
    W. Frishman, D. Glicklich · 2014 · Current Atherosclerosis Reports
95. Hipertensión arterial resistente
    Pedro Armario, Anna Oliveras, Alejandro de la Sierra · 2014 · Hipertensión y Riesgo Vascular
96. Hypertension – a clinical update for physicians
    Muntaser D. Musameh, Maciej Tomaszewski, Bryan Williams · 2013 · Clinical Medicine
97. Resistant Hypertension: A Comprehensive Overview
    Jacob Colin Jentzer · 2013 · Journal of Hypertension Open Access
98. InnovaSEC en acción: coste-efectividad de Barostim para el tratamiento de la hipertensión arterial refractaria en España
    Marcelo Soto, Laura Sampietro-Colom, Joan Sagarra, Josép Brugada · 2016 · Revista Española de Cardiología
99. Resistant Hypertension: An Incurable Disease or Just a Challenge For Our Medical Skill?
    Marina Di Pilla, Rosa María Bruno, Stefano Taddei · 2016 · High Blood Pressure & Cardiovascular Prevention
100. Device-based treatments in hypertension
     Jens Jordan, Guido M. Grassi, Jens Tank · 2016 · Journal of Hypertension